Evidence map›Paper›PMID 42531203›Full record

ArticlePloS one2026

Walking the tightrope of justifiable decision‑making: An exploratory qualitative study identifying barriers and solutions to efficient safety reporting.

Jemima Thompson, Macey L Murray, Matthew R Sydes, Annabelle South, Sharon B Love

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jemima ThompsonUCL Innovative Clinical Trials Unit, Institute of Clinical Trials and Methodology, UCL, London, United Kingdom.ORCID https://orcid.org/0000-0002-1853-3599
Macey L MurrayUCL Innovative Clinical Trials Unit, Institute of Clinical Trials and Methodology, UCL, London, United Kingdom.
Matthew R SydesUCL Innovative Clinical Trials Unit, Institute of Clinical Trials and Methodology, UCL, London, United Kingdom.ORCID https://orcid.org/0000-0002-9323-1371
Annabelle SouthUCL Innovative Clinical Trials Unit, Institute of Clinical Trials and Methodology, UCL, London, United Kingdom.ORCID https://orcid.org/0000-0001-8912-2001
Sharon B LoveUCL Innovative Clinical Trials Unit, Institute of Clinical Trials and Methodology, UCL, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSafety reporting is integral to clinical trial conduct, aiming to protect the rights and safety of trial participants and future patients. Over time, reporting safety events has become increasingly complex, leading to inefficiencies which place extra burden on trial staff and potentially impact patient safety. Attempts have been made to streamline these processes. However, effecting change in practice is challenging. Changes to UK trial regulations introduced in 2025 may reduce inefficiencies. To incorporate these changes effectively, we need to understand what barriers exist for their implementation. This study aimed to identify barriers and solutions to efficient safety reporting processes from the perspective of staff working at registered academic trials units in the UK, with a view to developing recommendations to enable the delivery of more efficient safety reporting practices.

methodThis was an exploratory, observational, qualitative focus group study of trials unit staff across the UK. Verbatim transcripts of the focus group discussions were analysed using Reflexive Thematic Analysis.

resultsTwenty-three CTU staff participated in four focus groups. One over-arching theme was generated from the analysis, "Walking on a tightrope: Making justifiable decisions". Participants felt that they were performing a balancing act between efficient, risk-proportionate safety reporting and risk-aversion. Possible solutions included clarification of expectations and improved transparency, and improved training and knowledge building. DISCUSSION: Despite efforts to streamline safety reporting processes, problems persist with the implementation of risk-proportionate approaches. Concerns that decisions will be deemed inadequate and impact patient safety and well-being make decision-making a difficult balancing-act. Confident decision-making by trial practitioners can be facilitated through access to resources and training provided by regulators, supported by tools and case studies. Trials unit level actions, such as mentoring schemes or platforms to share knowledge and learning, can support knowledge building and confidence development.

Indexed as

Clinical Trials as TopicDecision MakingPatient SafetyFocus GroupsHumansQualitative ResearchUnited Kingdom

Identifiers

PMID42531203
PMCPMC13422843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.